SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-121786
Filing Date
2020-04-28
Accepted
2020-04-28 06:13:35
Documents
3
Period of Report
2020-04-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d899956d8k.htm 8-K 18561
2 EX-99.1 d899956dex991.htm EX-99.1 6649
3 GRAPHIC g899956g90s02.jpg GRAPHIC 2636
  Complete submission text file 0001193125-20-121786.txt   30182
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 20822159
SIC: 2834 Pharmaceutical Preparations